Panuveitis
Links shared publicly online about this topic
Vogt-Koyanagi-Harada Syndrome: eMedicine Dermatology
emedicine.medscape.com — “Overview: Vogt-Koyanagi-Harada (VKH) syndrome is a rare systemic disease involving various melanocyte-containing organs. Bilateral panuveitis associated with cutaneous, neurologic, and auditory abnormalities are manifestations of this inflammatory granulomatous disorder. As first described by Vogt in 1906 and ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 21, 2010 at 11:07 pm By:
Susan Scroggins Health Advocate and Active Health Library
Vogt-Koyanagi-Harada (VKH) syndrome is a multisystem disorder that is uncommon. Learn the causes & symptoms. http://bit.ly/cny34e
Orphan Drug Status for Sirolimus for Non-Infectious Uveitis - MPR
empr.com — “Santen Inc. announced that the FDA has granted orphan drug designation for sirolimus (DE-109) for the treatment of chronic/refractory anterior non-infectious uveitis, non-infectious intermediate uveitis, non-infectious panuveitis, and non-infectious uveitis affecting the posterior segment of the eye.” View full resource at empr.com
Most Recently Shared on November 11, 2011 at 2:32 pm By:
Orphan Drug Status for Sirolimus for Non-Infectious #Uveitis http://t.co/vLl947Hz
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Susan Scroggins
Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
